Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Proves program value
a tech company might allocate $50 million in R&D for a new product
The firm's investment in R&D was 12% of revenue in 2024
Dynamically visualize your portfolio with a data-driven BCG matrix
simplifying portfolio decisions for executives and teams
EVOLENT HEALTH PORTER'S FIVE FORCES TEMPLATE RESEARCH B_180 Proves program valueDon't Miss the Bigger Picture Evolent Health faces moderate supplier leverage and rising buyer scrutiny as value based care accelerates, while regulatory shifts and tech enabled entrants heighten competitive pressure yet its scale and payer partnerships offer defensive advantages. This brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Evolent Health's competitive dynamics, market pressures, and
US$ 40.00
US$ 19.02
US$ 194.00
US$ 26.00
US$ 22.00
US$ 30.00
US$ 23.00
US$ 75.00
US$ 21.00
US$ 42.00
US$ 25.00
US$ 18.00
